1. Home
  2. SPRY vs BOW Comparison

SPRY vs BOW Comparison

Compare SPRY & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • BOW
  • Stock Information
  • Founded
  • SPRY 2015
  • BOW 2020
  • Country
  • SPRY United States
  • BOW United States
  • Employees
  • SPRY 160
  • BOW N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • BOW Property-Casualty Insurers
  • Sector
  • SPRY Health Care
  • BOW Finance
  • Exchange
  • SPRY Nasdaq
  • BOW Nasdaq
  • Market Cap
  • SPRY 1.4B
  • BOW 1.1B
  • IPO Year
  • SPRY N/A
  • BOW 2024
  • Fundamental
  • Price
  • SPRY $13.44
  • BOW $39.54
  • Analyst Decision
  • SPRY Strong Buy
  • BOW Buy
  • Analyst Count
  • SPRY 4
  • BOW 6
  • Target Price
  • SPRY $28.75
  • BOW $37.50
  • AVG Volume (30 Days)
  • SPRY 1.2M
  • BOW 286.7K
  • Earning Date
  • SPRY 05-14-2025
  • BOW 05-06-2025
  • Dividend Yield
  • SPRY N/A
  • BOW N/A
  • EPS Growth
  • SPRY N/A
  • BOW 18.99
  • EPS
  • SPRY 0.08
  • BOW 1.33
  • Revenue
  • SPRY $89,149,000.00
  • BOW $457,704,000.00
  • Revenue This Year
  • SPRY $1.49
  • BOW $25.34
  • Revenue Next Year
  • SPRY $141.68
  • BOW $20.94
  • P/E Ratio
  • SPRY $168.00
  • BOW $29.65
  • Revenue Growth
  • SPRY 297063.34
  • BOW 45.29
  • 52 Week Low
  • SPRY $7.55
  • BOW $22.14
  • 52 Week High
  • SPRY $18.51
  • BOW $42.29
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 46.69
  • BOW N/A
  • Support Level
  • SPRY $13.06
  • BOW N/A
  • Resistance Level
  • SPRY $15.06
  • BOW N/A
  • Average True Range (ATR)
  • SPRY 0.67
  • BOW 0.00
  • MACD
  • SPRY -0.18
  • BOW 0.00
  • Stochastic Oscillator
  • SPRY 15.97
  • BOW 0.00

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About BOW Bowhead Specialty Holdings Inc. Common Stock

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

Share on Social Networks: